These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 30762820

  • 21. Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation.
    Jois B, Asopa R, Basu S.
    Clin Nucl Med; 2014 Jun; 39(6):505-10. PubMed ID: 24662668
    [Abstract] [Full Text] [Related]

  • 22. Small Bowel Carcinoid: The "Dancing Bowel Sign" on 18F-FDOPA PET/CT.
    Helali M, Heimburger C, Rohr S, Goichot B, Imperiale A.
    Clin Nucl Med; 2016 Dec; 41(12):944-945. PubMed ID: 27749424
    [Abstract] [Full Text] [Related]

  • 23. Carcinoid tumors of the small-bowel: evaluation with 64-section CT-enteroclysis.
    Soyer P, Dohan A, Eveno C, Dray X, Hamzi L, Hoeffel C, Kaci R, Boudiaf M.
    Eur J Radiol; 2013 Jun; 82(6):943-50. PubMed ID: 23480964
    [Abstract] [Full Text] [Related]

  • 24. Adolescent With 68Ga DOTATATE-Avid Vertebral Hemangioma Mimicking Metastasis in PET Imaging.
    Skoura E, Alshammari A, Syed R, Sajjan R, Bomanji J.
    Clin Nucl Med; 2015 Jul; 40(7):e378-9. PubMed ID: 25783517
    [Abstract] [Full Text] [Related]

  • 25. 68Ga-DOTATATE PET/CT in Nonneuroendocrine Tumors: A Pictorial Essay.
    Yamaga LYI, Wagner J, Funari MBG.
    Clin Nucl Med; 2017 Jun; 42(6):e313-e316. PubMed ID: 28240663
    [Abstract] [Full Text] [Related]

  • 26. ACR Practice Parameter for the Performance of Gallium-68 DOTATATE PET/CT for Neuroendocrine Tumors.
    Subramaniam RM, Bradshaw ML, Lewis K, Pinho D, Shah C, Walker RC.
    Clin Nucl Med; 2018 Dec; 43(12):899-908. PubMed ID: 30394933
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.
    Morgat C, Vélayoudom-Céphise FL, Schwartz P, Guyot M, Gaye D, Vimont D, Schulz J, Mazère J, Nunes ML, Smith D, Hindié E, Fernandez P, Tabarin A.
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1258-66. PubMed ID: 26819103
    [Abstract] [Full Text] [Related]

  • 28. PET/CT using ¹⁸F-FDOPA provides improved staging of carcinoid tumor patients in a Canadian setting.
    Yakemchuk VN, Jager PL, Chirakal R, Reid R, Major P, Gulenchyn KY.
    Nucl Med Commun; 2012 Mar; 33(3):322-30. PubMed ID: 22183015
    [Abstract] [Full Text] [Related]

  • 29. The Impact of 68Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United Kingdom.
    Skoura E, Michopoulou S, Mohmaduvesh M, Panagiotidis E, Al Harbi M, Toumpanakis C, Almukhailed O, Kayani I, Syed R, Navalkissoor S, Ell PJ, Caplin ME, Bomanji J.
    J Nucl Med; 2016 Jan; 57(1):34-40. PubMed ID: 26471695
    [Abstract] [Full Text] [Related]

  • 30. Solitary choroidal metastasis from atypical carcinoid of the lung detected by (68)Ga DOTATATE PET/CT.
    Rapicetta C, Falco F, Roncali M, Treglia G, Carbonelli C, Paci M, Marchi S, Lococo F.
    Clin Nucl Med; 2015 Jun; 40(6):e319-20. PubMed ID: 25546202
    [Abstract] [Full Text] [Related]

  • 31. [Somatostatin receptor scintigraphy. A new imaging procedure for the specific demonstration of carcinoids of the small intestine].
    Dörr U, Räth U, Schürmann G, Höring E, Bach D, Wurm K, Scholz M, Adrian HJ, Bihl H.
    Rofo; 1993 Jan; 158(1):67-73. PubMed ID: 8425079
    [Abstract] [Full Text] [Related]

  • 32. Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors.
    Panagiotidis E, Alshammari A, Michopoulou S, Skoura E, Naik K, Maragkoudakis E, Mohmaduvesh M, Al-Harbi M, Belda M, Caplin ME, Toumpanakis C, Bomanji J.
    J Nucl Med; 2017 Jan; 58(1):91-96. PubMed ID: 27516446
    [Abstract] [Full Text] [Related]

  • 33. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
    Archier A, Varoquaux A, Garrigue P, Montava M, Guerin C, Gabriel S, Beschmout E, Morange I, Fakhry N, Castinetti F, Sebag F, Barlier A, Loundou A, Guillet B, Pacak K, Taïeb D.
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1248-57. PubMed ID: 26637204
    [Abstract] [Full Text] [Related]

  • 34. Value of CT enteroclysis in suspected small-bowel carcinoid tumors.
    Kamaoui I, De-Luca V, Ficarelli S, Mennesson N, Lombard-Bohas C, Pilleul F.
    AJR Am J Roentgenol; 2010 Mar; 194(3):629-33. PubMed ID: 20173138
    [Abstract] [Full Text] [Related]

  • 35. 68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors.
    Poeppel TD, Binse I, Petersenn S, Lahner H, Schott M, Antoch G, Brandau W, Bockisch A, Boy C.
    J Nucl Med; 2011 Dec; 52(12):1864-70. PubMed ID: 22072704
    [Abstract] [Full Text] [Related]

  • 36. The value of somatostatin receptor imaging with In-111 Octreotide and/or Ga-68 DOTATATE in localizing Ectopic ACTH producing tumors.
    Özkan ZG, Kuyumcu S, Balköse D, Ozkan B, Aksakal N, Yılmaz E, Sanlı Y, Türkmen C, Aral F, Adalet I.
    Mol Imaging Radionucl Ther; 2013 Aug; 22(2):49-55. PubMed ID: 24003397
    [Abstract] [Full Text] [Related]

  • 37. A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.
    Kayani I, Conry BG, Groves AM, Win T, Dickson J, Caplin M, Bomanji JB.
    J Nucl Med; 2009 Dec; 50(12):1927-32. PubMed ID: 19910422
    [Abstract] [Full Text] [Related]

  • 38. Value of the 68Ga-DOTATATE PET-CT in the diagnosis of endometriosis. A pilot study.
    Fastrez M, Artigas C, Sirtaine N, Wimana Z, Caillet M, Rozenberg S, Flamen P.
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():69-74. PubMed ID: 28342392
    [Abstract] [Full Text] [Related]

  • 39. 68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients.
    Fendler WP, Barrio M, Spick C, Allen-Auerbach M, Ambrosini V, Benz M, Bluemel C, Grewal RK, Lapa C, Miederer M, Nicolas G, Schuster T, Czernin J, Herrmann K.
    J Nucl Med; 2017 Feb; 58(2):307-311. PubMed ID: 27539839
    [Abstract] [Full Text] [Related]

  • 40. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report.
    Lobrano MB, McCarthy K, Adams L, Neitzschman H.
    Am J Gastroenterol; 1997 Mar; 92(3):513-5. PubMed ID: 9068482
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.